Konica Minolta Launches New Handheld Ultrasound Device
Optimized for musculoskeletal assessment, needle guidance and vascular access, the PocketPro H2 wireless ultrasound unit reportedly provides 90 minutes of high-quality continuous scanning for point-of-care applications.
Combining ease of use features, strong compatibility with existing systems and robust image quality, Konica Minolta has launched the handheld, wireless ultrasound device PocketPro H2.
The ultrasound device reportedly facilitates rapid soft tissue assessment of ligaments, muscles, cartilage, inflammation, and joint instability, according to Konica Minolta. The company said clinicians can also employ the PocketPro H2 ultrasound for vascular access and needle guidance applications.
In addition to color and pulsed-wave Doppler capabilities and M-Mode functions, the PocketPro H2 offers an ergonomic design and customized imaging presets that promote ease of use.
The company noted a downloadable app allows wireless connection of the PocketPro H2 to the majority of iOS and Android smart devices and viewing of images at the point of care. Fully DICOM-compatible, the PocketPro H2 can also be linked to any PACS platform, according to Konica Minolta.
“Ultrasound has been called the new stethoscope of the 21st century and this advanced, wireless handheld unit helps clinicians do more with ultrasound at the point of care,” noted Joan Toth, a senior product marketing manager of ultrasound at Konica Minolta Healthcare.
(Editor’s note: For related content, see “Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference” and “New System Combines Diagnostic Ultrasound and Transient Elastography.”)
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
